AAAAAA

   
Results: 1-3 |
Results: 3
IN-VIVO CLEARANCE OF ETHOXYCOUMARIN AND ITS PREDICTION FROM IN-VITRO SYSTEMS - USE OF DRUG DEPLETION AND METABOLITE FORMATION METHODS IN HEPATIC MICROSOMES AND ISOLATED HEPATOCYTES
Authors: CARLILE DJ STEVENS AJ ASHFORTH EIL WAGHELA D HOUSTON JB
Citation: Dj. Carlile et al., IN-VIVO CLEARANCE OF ETHOXYCOUMARIN AND ITS PREDICTION FROM IN-VITRO SYSTEMS - USE OF DRUG DEPLETION AND METABOLITE FORMATION METHODS IN HEPATIC MICROSOMES AND ISOLATED HEPATOCYTES, Drug metabolism and disposition, 26(3), 1998, pp. 216-221
PREDICTION OF IN-VIVO DISPOSITION FROM IN-VITRO SYSTEMS - CLEARANCE OF PHENYTOIN AND TOLBUTAMIDE USING RAT HEPATIC-MICROSOMAL AND HEPATOCYTE DATA
Authors: ASHFORTH EIL CARLILE DJ CHENERY R HOUSTON JB
Citation: Eil. Ashforth et al., PREDICTION OF IN-VIVO DISPOSITION FROM IN-VITRO SYSTEMS - CLEARANCE OF PHENYTOIN AND TOLBUTAMIDE USING RAT HEPATIC-MICROSOMAL AND HEPATOCYTE DATA, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 761-766
THE PHARMACOKINETICS OF ONDANSETRON AFTER INTRAVENOUS-INJECTION IN HEALTHY-VOLUNTEERS PHENOTYPED AS POOR OR EXTENSIVE METABOLIZERS OF DEBRISOQUINE
Authors: ASHFORTH EIL PALMER JL BYE A BEDDING A
Citation: Eil. Ashforth et al., THE PHARMACOKINETICS OF ONDANSETRON AFTER INTRAVENOUS-INJECTION IN HEALTHY-VOLUNTEERS PHENOTYPED AS POOR OR EXTENSIVE METABOLIZERS OF DEBRISOQUINE, British journal of clinical pharmacology, 37(4), 1994, pp. 389-391
Risultati: 1-3 |